Involvement of cholecystokinin in peripheral nociceptive sensitization during diabetes in rats as revealed by the formalin response

Pain

Volumn 122, Issue 1-2, 2006, Pages 118-125

  Juárez Rojop, Isela E ^a,d   Granados Soto, Vinicio ^b   Díaz Zagoya, Juan C ^a,c   Flores Murrieta, Francisco J ^d,e   Torres López, Jorge E ^a  

^a UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^e SECRETARÍA DE SALUD   (Mexico)

Author keywords

CCK 8; CCKB receptors; Diabetes; Inflammatory pain

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; FORMALDEHYDE; ITRIGLUMIDE; LORGLUMIDE; PROGLUMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; HORMONE RELEASE; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; DIABETES COMPLICATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE; FORMALDEHYDE; HYPERALGESIA; PAIN THRESHOLD; RATS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; SINCALIDE;

EID: 33646051825     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.01.018     Document Type: Article

References (47)

1. Abramov A.V., Kolesnik I.M., Trzhetsinskii S.D., and Orlovskii M.A. Changes in the cholecystokinin-synthetizing hypothalamic system during experimental diabetes mellitus in rats. Morfologiia 114 (1998) 27-31
2. Adeghate E. Effect of subcutaneous pancreatic tissue transplants on streptozotocin-induced diabetes in rats. III. Distribution of neuropeptides in normal and diabetic (host) pancreas. Tissue Cell 31 (1999) 84-89
3. Antunes-Bras J.M., Laporte A.M., Benoliel J.J., Bourgoin S., Mauborgne A., Hamon M., et al. Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cord. J Neurochem 72 (1999) 858-867
4. Araiza-Saldaña C.I., Reyes-García G., Bermúdez-Ocaña D.Y., Pérez-Severiano F., and Granados-Soto V. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. Eur J Pharmacol 527 (2005) 60-70
5. Baber N.S., Dourish C.T., and Hill D.R. The role of CCK, caerulein, and CCK antagonists in nociception. Pain 39 (1989) 307-328
6. Broberger C., Farkas-Szallasi T., Szallasi A., Lundberg J.M., Hokfelt T., Wiesenfeld-Hallin Z., et al. Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies. Pain 84 (2000) 21-28
7. Burchiel K.J., Russell L.C., Lee R.P., and Sima A.A. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain. Diabetes 34 (1985) 1210-1213
8. Calcutt N.A., Jorge M.C., Yaksh T.L., and Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68 (1996) 293-299
9. Calcutt N.A., Li L., Yaksh T.L., and Malmberg A.B. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur J Pharmacol 285 (1995) 189-197
10. Calcutt N.A., and Malmberg A.B. Basal and formalin-evoked spinal levels of amino acids in conscious diabetic rats (Abstract). Soc Neurosci Abs 21 (1995) 650
11. Calcutt N.A., Malmberg A.B., Yamamoto T., and Yaksh T.L. Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain 58 (1994) 413-420
12. Calcutt N.A., Stiller C., Gustafsson H., and Malmberg A.B. Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Res 856 (2000) 20-27
13. Capone F., and Aloisi A.M. Refinement of pain evaluation techniques. The formalin test. Ann Ist Super Sanita 40 (2004) 223-229
14. Ceseña R.M., and Calcutt N.A. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. Neurosci Lett 262 (1999) 101-104
15. Chen S.R., and Pan H.L. Spinal endogenous acetylcholine contributes to the analgesic effect of systemic morphine in rats. Anesthesiology 95 (2001) 525-530
16. Chen X., and Levine J.D. Hyper-responsivity in a subset of C-fiber nociceptors in a model of painful diabetic neuropathy in the rat. Neuroscience 102 (2001) 185-192
17. Corp E.S., McQuade J., Moran T.H., and Smith G.P. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res 623 (1993) 161-166
18. Cortés R., Arvidsson U., Schalling M., Ceccatelli S., and Hokfelt T. In situ hybridization studies on mRNAs for cholecystokinin, calcitonin gene-related peptide and choline acetyltransferase in the lower brain stem, spinal cord and dorsal root ganglia of rat and guinea pig with special reference to motoneurons. J Chem Neuroanat 3 (1990) 467-485
19. Coudoré-Civiale M.A., Courteix C., Fialip J., Boucher M., and Eschalier A. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats. Pain 88 (2000) 15-22
20. Courteix C., Eschalier A., and Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53 (1993) 81-88
21. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
22. Fox A., Eastwood C., Gentry C., Manning D., and Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81 (1999) 307-316
23. Freshwater J.D., Svensson C.I., Malmberg A.B., and Calcutt N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51 (2002) 2249-2255
24. Friedrich A.E., and Gebhart G.F. Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla. Pain 104 (2003) 93-101
25. Ghilardi J.R., Allen C.J., Vigna S.R., McVey D.C., and Mantyh P.W. Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions. J Neurosci 12 (1992) 4854-4866
26. Hill D.R., and Woodruff G.N. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res 526 (1990) 276-283
27. 2 release. Neuroreport 8 (1997) 2325-2329
28. Kamei J., and Zushida K. The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice. Brain Res 892 (2001) 370-375
29. Kovelowski C.J., Ossipov M.H., Sun H., Lai J., Malan T.P., and Porreca F. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain 87 (2000) 265-273
30. B receptor antagonist. Eur J Pharmacol 369 (1999) 81-90
31. Malcangio M., and Tomlinson D.R. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 76 (1998) 151-157
32. Moran T.H., Robinson P.H., Goldrich M.S., and McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362 (1986) 175-179
33. B receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test. Eur J Pharmacol 273 (1995) 145-151
34. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., et al. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 51 (1999) 745-781
35. B antagonist in the rat. Neurosci Lett 181 (1994) 9-12
36. Schäfer M., Zhou L., and Stein C. Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 82 (1998) 603-611
37. Seroogy K.B., Mohapatra N.K., Lund P.K., Rethelyi M., McGehee D.S., and Perl E.R. Species-specific expression of cholecystokinin messenger RNA in rodent dorsal root ganglia. Brain Res Mol Brain Res 7 (1990) 171-176
38. Stanfa L., Dickenson A., Xu X.J., and Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sci 15 (1994) 65-66
39. Urban M.O., Jiang M.C., and Gebhart G.F. Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil. Brain Res 737 (1996) 83-91
40. B receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception. Neuroreport 5 (1994) 2601-2605
41. Verge V.M., Wiesenfeld-Hallin Z., and Hokfelt T. Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey. Eur J Neurosci 5 (1993) 240-250
42. Wheeler-Aceto H., and Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 104 (1991) 35-44
43. Willetts J., Urban L., Murase K., and Randic M. Actions of cholecystokinin octapeptide on rat spinal dorsal horn neurons. Ann N Y Acad Sci 448 (1985) 385-402
44. Xu X.J., Hokfelt T., Hughes J., and Wiesenfeld-Hallin Z. The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats. Neuroreport 5 (1994) 718-720
45. Xu X.J., Puke M.J., Verge V.M., Wiesenfeld-Hallin Z., Hughes J., and Hokfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Lett 152 (1993) 129-132
46. Zhang X., Dagerlind A., Elde R.P., Castel M.N., Broberger C., Wiesenfeld-Hallin Z., et al. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience 57 (1993) 227-233
47. Zimmermann M. Ethical guidelines for investigations on experimental pain in conscious animals. Pain 16 (1983) 109-110